Luye Pharma Group's total assets for Q4 2024 were ¥29.61B, an increase of 8.87% from the previous quarter. HK:2186 total liabilities were ¥13.86B for the fiscal quarter, a 5.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.